Drug: lisinopril Quarter: 2016Q3
Total Drug/Injury Combinations: 1,460 Number of Pages: 73
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| LISINOPRIL/HCTZ | Dysgeusia | 1 | view events |
| LISINOPRIL/HCTZ | Dyspnoea | 1 | view events |
| Lisinopril/HCTZ | Leukocytosis | 1 | view events |
| Lisinopril/HCTZ | Malaise | 1 | view events |
| Lisinopril/HCTZ | Muscular weakness | 1 | view events |
| Lisinopril/HCTZ | Myalgia | 1 | view events |
| LISINOPRIL/HCTZ | Nausea | 1 | view events |
| LISINOPRIL/HCTZ | Off label use | 1 | view events |
| LISINOPRIL/HCTZ | Pneumonia | 1 | view events |
| LISINOPRIL/HCTZ | Respiratory tract oedema | 1 | view events |
| Lisinopril/HCTZ | Rhabdomyolysis | 1 | view events |
| Lisinopril/HCTZ | Urine output decreased | 1 | view events |
| LISINOPRIL/HCTZ TABLETS | Cough | 1 | view events |
| LISINOPRIL/HCTZ TABLETS | Drug ineffective | 1 | view events |
| LISINOPRIL/HCTZ TABLETS | Feeling hot | 1 | view events |
| Lisinopril/Hydrochlorothiazide 20/25 (Watson Laboratories) | Anxiety | 1 | view events |
| Lisinopril/Hydrochlorothiazide 20/25 (Watson Laboratories) | Blood pressure increased | 1 | view events |
| Lisinopril/Hydrochlorothiazide 20/25 (Watson Laboratories) | Fluid retention | 1 | view events |
| Lisinopril/Hydrochlorothiazide 20/25 (Watson Laboratories) | Nervousness | 1 | view events |
| Lisinopril/Hydrochlorothiazide 20/25 (Watson Laboratories) | Urine flow decreased | 1 | view events |
Total Drug/Injury Combinations: 1,460 Number of Pages: 73
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)